Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Engines of Innovation: Cramer's 'Mad Money' Recap (Wednesday 1/13/21)
By Scott Rutt
Jan 13, 2021 8:48 PM EST
JIM CRAMER
Engines of Innovation: Cramer's 'Mad Money' Recap (Wednesday 1/13/21)
By Scott Rutt
Jan 13, 2021 8:48 PM EST
PRESS RELEASES
TG Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference
By GlobeNewswire
Jan 8, 2021 7:00 AM EST
PRESS RELEASES
TG Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
By GlobeNewswire
Dec 14, 2020 7:51 PM EST
INVESTING
Silver Spike, Immutep, 8x8: 5 Top Stock Gainers for Thursday
By Rob Lenihan
Dec 10, 2020 4:23 PM EST
INVESTING
TG Therapeutics Soars on Positive Results for MS Treatment
By Rob Lenihan
Dec 10, 2020 2:24 PM EST
PRESS RELEASES
TG Therapeutics Announces Pivotal Data From The UNITY-CLL And UNITY-NHL Clinical Trials Presented At The 62nd American Society Of Hematology Annual Meeting
By GlobeNewswire
Dec 7, 2020 10:15 AM EST
PRESS RELEASES
TG Therapeutics Announces Publication Of Phase 2 Data Evaluating Umbralisib In Patients With Chronic Lymphocytic Leukemia Who Are Intolerant To Prior BTK Or PI3K Inhibitor Therapy In Blood
By GlobeNewswire
Dec 2, 2020 7:15 AM EST
PRESS RELEASES
TG Therapeutics Initiates Rolling Submission Of Biologics License Application To U.S. Food And Drug Administration For Ublituximab In Combination With Umbralisib As A Treatment For Patients With Chronic Lymphocytic Leukemia
By GlobeNewswire
Dec 1, 2020 7:00 AM EST
PRESS RELEASES
TG Therapeutics To Participate In The Jefferies Virtual London Healthcare Conference
By GlobeNewswire
Nov 13, 2020 7:00 AM EST
PRESS RELEASES
TG Therapeutics Announces Data Presentations At The Upcoming 62nd American Society Of Hematology Annual Meeting And Exposition
By GlobeNewswire
Nov 2, 2020 7:00 AM EST
PRESS RELEASES
TG Therapeutics Announces Fast Track Designation Granted By The FDA To Ublituximab In Combination With Umbralisib For The Treatment Of Adult Patients With Chronic Lymphocytic Leukemia
By GlobeNewswire
Oct 21, 2020 7:30 AM EDT
JIM CRAMER
Biden Portfolio: Cramer's 'Mad Money' Recap (Tuesday 10/20/20)
By Scott Rutt
Oct 20, 2020 10:27 PM EDT
PRESS RELEASES
TG Therapeutics To Present At Upcoming Investor Conferences
By GlobeNewswire
Sep 9, 2020 9:17 AM EDT
PRESS RELEASES
TG Therapeutics Announces FDA Acceptance Of New Drug Application For Umbralisib As A Treatment For Patients With Previously Treated Marginal Zone Lymphoma And Follicular Lymphoma
By GlobeNewswire
Aug 13, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics To Host Conference Call On Second Quarter 2020 Financial Results And Business Update
By GlobeNewswire
Aug 6, 2020 7:30 AM EDT
PRESS RELEASES
TG Therapeutics Completes Rolling Submission Of New Drug Application To The U.S. Food And Drug Administration For Umbralisib As A Treatment For Patients With Previously Treated Marginal Zone Lymphoma Or Follicular Lymphoma
By GlobeNewswire
Jun 17, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics Announces Data Presentations At The 25th European Hematology Association (EHA) Annual Congress
By GlobeNewswire
Jun 12, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics To Present At The Goldman Sachs 41st Annual Global Healthcare Conference
By GlobeNewswire
Jun 9, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics To Present At The Jefferies 2020 Healthcare Conference
By GlobeNewswire
Jun 2, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics Announces Preclinical Data Presentation At The Upcoming American Association For Cancer Research Annual Meeting
By GlobeNewswire
May 15, 2020 7:00 AM EDT
PRESS RELEASES
TG Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
By GlobeNewswire
May 14, 2020 10:08 PM EDT
PRESS RELEASES
TG Therapeutics Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
May 14, 2020 4:01 PM EDT
PRESS RELEASES
TG Therapeutics Announces Data Presentations At Upcoming Medical Meetings
By GlobeNewswire
May 14, 2020 9:27 AM EDT
PRESS RELEASES
TG Therapeutics Strengthens Executive Team With The Addition Of Owen A. O'Connor, MD, PhD, As Chief Scientific Officer
By GlobeNewswire
May 8, 2020 7:00 AM EDT
